The U.S. flu scene & peramivir
While we wipe away yet another tear for the never-ending demise of Brett Favre, there is some good news emanating from CDC:
Summary of Weekly FluView (http://www.cdc.gov/flu/weekly/summary.htm)
Meanwhile, IV peramivir seems to be an effective therapeutic agent for seasonal flu. The study looked at a single intravenous dose of the neuraminidase inhibitor. The drug reduced the duration of influenza (mostly H1N1 strain) symptoms when compared to placebo and was well tolerated among 300 healthy outpatients with confirmed flu. No serious side effects were noted. The study involved healthy subjects, however. So we really don’t know what the result would be for really sick or chronically compromised flu patients. Link to the abstract: http://aac.asm.org/cgi/content/abstract/54/11/4568.